Lancet and Pen Needles Market Research Report – Global Forecast Till 2027

$4,450$6,250

Lancet and Pen Needles Market Information: By Type (Push Button Safety Lancets, Pressure Activated Safety Lancets And Side Button Safety Lancets), Application (Insulin, Capillary Blood Sampling, Hormones, Skin Testing) End-User – Global Forecast Till 2027

Clear
SKU: 190514 Categories: , Tags: ,

Description

Market Analysis
For obtaining blood samples, Lancets are used as alternative devices. Lancets are getting worldwide acknowledgment and acceptance because of its convenient features which provide an edge over the customary strategies for vein puncture. Some of the essential highlights of the safety lancets are painless vein cut, safety while using and easier handling. The safety lancets and its major applications include cholesterol test, capillary blood microsampling, HIV screening test, and hemoglobin (HBO) test, blood group test, allergy tests, coagulation tests, several other blood-based tests.
Various factors, for example, the positive repayment condition and government support in chosen nations, benefits of insulin pens over vials and syringes, innovative headways to needle and pain tension, increasing number of diabetic populaces, and different gatherings, meetings, and congresses to make pen needle awareness is required to drive the development of the pen needles market amid the forecast period (2017-2023). In any case, the hazard related with blood transfusion may influence the development of the global lancet and pen needles market contrarily.
Market Segmentation
The global lancet and pen needles market is divided on the basis of its type, end-user, application, and regional analysis. Based on its type, the global market is divided into lancets and pen needles. On the basis of its application, the global lancet and pen needles market is segmented into skin testing, insulin, hormones, capillary blood sampling, GLP, and others. Based on its end users, the market is segmented into medical institutions & diagnostic centers, hospitals & clinics, research & academic laboratories, home care & home diagnostics, and others.
Regional Analysis
Geographically, the global lancet and pen needles market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
Some of the major industry players in the global lancet and pen needles market are B. Braun Melsungen AG, Becton Dickinson, Terumo Corporation, Sanofi, Bayer AG, F. Hoffmann-La Roche AG, Novo Nordisk A S, Owen Mumford Ltd, Eli Lilly and Company, Medtronic, Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio One, HTL-STREFA S.A, Abbott Laboratories, Improve Medical, Allison Medical, Inc., UltiMed, Inc., Artsana S.p.a., Perrigo Diabetes Care, VOGT MEDICAL, MedExel Co., Ltd, Simple Diagnostics, ARKRAY Inc., Stat Medical, Trividia Health, Terumo, among others.

Table of Contents

Table of Contents:

1 Report Prologue
1.1 Increasing awareness of lancet and pen needles:
1.2 Production of lancet and pen needles:
1.3 FDA Regulation for Lancet:
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of diabetes
4.2.2 Growing incidence number of contagious and non-contagious diseases
4.2.3 Increasing inclination towards home healthcare
4.2.4 Improving Medical Device Regulation
4.3 Restraints
4.3.1 Risk associated with blood transfusion
4.3.2 Growing adoption of oral drug delivery systems, reuse of pen needles and infusion sets
4.4 Opportunities
4.5 Mega Trends:
4.6 Macroeconomic Indicators

5 Market Factor Analysis
5.1 Porter’s Five forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 R&D
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-sales Monitoring
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
6 Global Lancet And Pen Needles Market, By Type
6.1 Lancet
6.1.1 Regular Lancet
6.1.2 Safety Lancet
6.1.2.1 Push Button Safety Lancet
6.1.2.2 Pressure Activated Safety Lancet
6.1.2.3 Side Button Safety Lancet
6.2 Pen Needles
6.2.1 Standard Needles
6.2.2 Safety Needles
7 Global Lancet And Pen Needles Market, By Application
7.1 Insulin
7.2 Capillary Blood Sampling
7.3 Hormones
7.4 Glucose Like Peptide (GLP)
7.5 Skin Testing
8 Global Lancet And Pen Needles Market, By End User
8.1 Hospitals & Clinics
8.2 Diagnostic Centers & Medical Institutions
8.3 Home Care & Home Diagnostics
8.4 Research & Academic Laboratories
9 Global Lancet and Pen Needles Market, By Region
9.1 Introduction
9.2 Europe
9.2.1 Western Europe
9.2.1.1 Germany
9.2.1.2 France
9.2.1.3 U.K
9.2.1.4 Italy
9.2.1.5 SPAIN
9.2.1.6 Rest of Western Europe
9.2.2 Eastern Europe
9.3 Americas
9.3.1 North America
9.3.1.1 U.S.
9.3.1.2 Canada
9.3.2 South America
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 UAE
9.5.2 Saudi Arabia
9.5.3 Kuwait
9.5.4 Qatar
9.5.5 Africa
10 Competitive Landscape
10.1 Introduction
10.1 Company Share Analysis
11 Company Profile
11.1 B. Braun Melsungen AG
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Products
11.1.4 Strategy
11.1.5 Key Developments
11.2 Terumo Corporation
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Products
11.2.4 Strategy
11.2.5 Key Developments
11.3 Becton Dickinson
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Products
11.3.4 Strategy
11.3.5 Key Developments
11.4 Sanofi
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Products
11.4.4 Strategy
11.4.5 Key Developments
11.5 F. Hoffmann-La Roche AG
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Products
11.5.4 Strategy
11.5.5 Key Developments
11.6 Bayer AG
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Products
11.6.4 Strategy
11.6.5 Key Developments
11.7 Novo Nordisk A S
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Products
11.7.4 Strategy
11.7.5 Key Developments
11.8 Eli Lilly and Company
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Products
11.8.4 Strategy
11.8.5 Key Developments
11.9 Owen Mumford Ltd
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Products
11.9.4 Strategy
11.9.5 Key Developments
11.1 Medtronic
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Products
11.10.4 Strategy
11.10.5 Key Developments
11.11 Ypsomed Holding AG
11.11.1 Company Overview
11.11.2 Financials
11.11.3 Products
11.11.4 Strategy
11.11.5 Key Developments
11.12 Sarstedt AG & Co
11.12.1 Company Overview
11.12.2 Financials
11.12.3 Products
11.12.4 Strategy
11.12.5 Key Developments
11.13 Greiner Bio One
11.13.1 Company Overview
11.13.2 Financials
11.13.3 Products
11.13.4 Strategy
11.13.5 Key Developments
11.14 Abbott Laboratories
11.14.1 Company Overview
11.14.2 Financials
11.14.3 Products
11.14.4 Strategy
11.14.5 Key Developments
11.15 HTL-STREFA S.A.
11.15.1 Company Overview
11.15.2 Financials
11.15.3 Products
11.15.4 Strategy
11.15.5 Key Developments
11.16 Improve Medical
11.16.1 Company Overview
11.16.2 Financials
11.16.3 Products
11.16.4 Strategy
11.16.5 Key Developments
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of lancet and pen needles Industry
13 Appendix
13.1 Discussion Blue Print

Additional information

Publisher

Geography Covered

Date Published

Pages

Format